{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:32:29Z","timestamp":1793413949267,"version":"4.5.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100016003","name":"Istanbul University Cerrahpa\u015fa","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100016003","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      Central nervous system (CNS) involvement is rare in ANCA-associated vasculitis (AAV). On the other hand, AAV patients may develop complications or other conditions that mimic CNS involvement. We aimed to present the clinical, laboratory and imaging features of our AAV patients with CNS involvement and conditions other than CNS involvement that caused neurologic symptoms\n                      <jats:bold>.<\/jats:bold>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>We surveyed the charts of 430\u00a0AAV patients in order to identify patients who were evaluated for neurologic symptoms suggesting CNS involvement. We extracted data on their demographics, AAV features, neurologic symptoms, final diagnoses after neurologic work-up, and their outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 430 AAV patients, 61 patients (14%) (41\u00a0GPA, 11 MPA, 9 EGPA; 27 women, 34 men; mean age: 51.6\u00a0\u00b1\u00a015.4 years) with neurologic symptoms were identified. At the time of the occurrence of neurologic symptoms, all patients had active disease [median (IQR) BVAS=11.9 (7\u201315)]. The causes of neurologic symptoms were CNS involvement of AAV in 7 patients (meningeal involvement in 3, ischemic cerebrovascular accident in 2, intracranial hypertension in 1, and cerebral venous sinus thrombosis in 1), other AAV manifestations such as ocular, orbital and nasopharyngeal involvement in 30, and drug-related adverse events or comorbidities mimicking CNS involvement such as infections, atherosclerotic or thromboembolic events in 15 patients. Neurologic work-up did not lead to an underlying condition in 9.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>CNS involvement was uncommon, observed in only 1.6% of patients. AAV manifestations other than CNS involvement, as well as complications like infections and cardiovascular disease may mimic CNS involvement in patients with AAV.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00415-025-13203-z","type":"journal-article","created":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:31:30Z","timestamp":1751934690000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Central nervous system involvement and mimickers in ANCA associated vasculitis"],"prefix":"10.1007","volume":"272","author":[{"given":"Yeliz","family":"Yagiz Ozogul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinem Nihal","family":"Esatoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Ozogul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osman","family":"Kizilkilic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yesim","family":"Ozguler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emire","family":"Seyahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serdal","family":"Ugurlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melike","family":"Melikoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izzet","family":"Fresko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vedat","family":"Hamuryudan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2866-4004","authenticated-orcid":false,"given":"Ugur","family":"Uygunoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulen","family":"Hatemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,8]]},"reference":[{"issue":"1","key":"13203_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F et al (2013) 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65(1):1\u201311. https:\/\/doi.org\/10.1002\/art.37715. (PubMed PMID: 23045170)","journal-title":"Arthritis Rheum"},{"issue":"1","key":"13203_CR2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41572-020-0204-y","volume":"6","author":"AR Kitching","year":"2020","unstructured":"Kitching AR, Anders HJ, Basu N, Brouwer E, Gordon J, Jayne DR et al (2020) ANCA-associated vasculitis. Nat Rev Dis Primers. 6(1):71. https:\/\/doi.org\/10.1038\/s41572-020-0204-y. (Epub 20200827 PubMed PMID: 32855422)","journal-title":"Nat Rev Dis Primers."},{"issue":"51","key":"13203_CR3","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000028305","volume":"100","author":"MA Dagostin","year":"2021","unstructured":"Dagostin MA, Nunes SLO, Shinjo SK, Pereira RMR (2021) Mortality predictors in ANCA-associated vasculitis: Experience of a Brazilian monocentric cohort of a rheumatology center. Medicine (Baltimore). 100(51):e28305. https:\/\/doi.org\/10.1097\/md.0000000000028305. (PubMed PMID: 34941119; PubMed Central PMCID: PMCPMC8702239)","journal-title":"Medicine (Baltimore)."},{"issue":"8","key":"13203_CR4","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/art.41773","volume":"73","author":"SA Chung","year":"2021","unstructured":"Chung SA, Langford CA, Maz M, Abril A, Gorelik M, Guyatt G et al (2021) 2021 American college of rheumatology\/vasculitis foundation guideline for the management of antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheumatol 73(8):1366\u201383. https:\/\/doi.org\/10.1002\/art.41773. (Epub 20210708 PubMed PMID: 34235894)","journal-title":"Arthritis Rheumatol"},{"key":"13203_CR5","volume-title":"StatPearls","author":"A Qasim","year":"2024","unstructured":"Qasim A, Patel JB (2024) ANCA positive vasculitis. StatPearls. StatPearls Publishing, Treasure Island (FL)"},{"key":"13203_CR6","doi-asserted-by":"publisher","first-page":"4808806","DOI":"10.1155\/2022\/4808806","volume":"202","author":"N Moollan","year":"2022","unstructured":"Moollan N, Ahmed AR, Denton M (2022) Management and outcomes of ANCA-associated vasculitis at a tertiary healthcare facility. Autoimmune Dis 202:4808806. https:\/\/doi.org\/10.1155\/2022\/4808806. (Epub 20220211 PubMed PMID: 35186331; PubMed Central PMCID: PMCPMC8856824)","journal-title":"Autoimmune Dis"},{"issue":"1","key":"13203_CR7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/s1474-4422(13)70236-9","volume":"13","author":"KG Gwathmey","year":"2014","unstructured":"Gwathmey KG, Burns TM, Collins MP, Dyck PJ (2014) Vasculitic neuropathies. Lancet Neurol 13(1):67\u201382. https:\/\/doi.org\/10.1016\/s1474-4422(13)70236-9. (PubMed PMID: 24331794)","journal-title":"Lancet Neurol"},{"key":"13203_CR8","first-page":"7","volume-title":"Demyelination disorders","author":"S Mouna","year":"2021","unstructured":"Mouna S, Faten F, Zouhir B (2021) Peripheral Neuropathy in ANCA Vasculitis. In: Stavros JB, Fabian HR, Welwin L (eds) Demyelination disorders. IntechOpen, Rijeka, p 7"},{"key":"13203_CR9","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.3389\/fneur.2018.01166","volume":"9","author":"Y Zheng","year":"2018","unstructured":"Zheng Y, Zhang Y, Cai M, Lai N, Chen Z, Ding M (2018) Central Nervous System Involvement in ANCA-Associated Vasculitis: What Neurologists Need to Know. Front Neurol 9:1166. https:\/\/doi.org\/10.3389\/fneur.2018.01166. (Epub 20190110 PubMed PMID: 30687221; PubMed Central PMCID: PMCPMC6335277)","journal-title":"Front Neurol"},{"issue":"3","key":"13203_CR10","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s10067-013-2420-2","volume":"34","author":"A S\u00f6derstr\u00f6m","year":"2015","unstructured":"S\u00f6derstr\u00f6m A, Revaz S, Dudler J (2015) Cranial neuropathies in granulomatosis with polyangiitis (Wegener\u2019s): a case-based review. Clin Rheumatol 34(3):591\u20136. https:\/\/doi.org\/10.1007\/s10067-013-2420-2. (Epub 20131219 PubMed PMID: 24352751)","journal-title":"Clin Rheumatol"},{"issue":"11","key":"13203_CR11","first-page":"671","volume":"87","author":"RA Luqmani","year":"1994","unstructured":"Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P et al (1994) Birmingham vasculitis activity score (BVAS) in systemic necrotizing vasculitis. Qjm 87(11):671\u20138 (PubMed PMID: 7820541)","journal-title":"Qjm"},{"issue":"1 Suppl 52","key":"13203_CR12","first-page":"S65","volume":"27","author":"W Zhang","year":"2009","unstructured":"Zhang W, Zhou G, Shi Q, Zhang X, Zeng XF, Zhang FC (2009) Clinical analysis of nervous system involvement in ANCA-associated systemic vasculitides. Clin Exp Rheumatol. 27(1 Suppl 52):S65-9 (PubMed PMID: 19646349)","journal-title":"Clin Exp Rheumatol."},{"issue":"3","key":"13203_CR13","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s10067-017-3835-y","volume":"37","author":"GE Fragoulis","year":"2018","unstructured":"Fragoulis GE, Lionaki S, Venetsanopoulou A, Vlachoyiannopoulos PG, Moutsopoulos HM, Tzioufas AG (2018) Central nervous system involvement in patients with granulomatosis with polyangiitis: a single-center retrospective study. Clin Rheumatol 37(3):737\u201347. https:\/\/doi.org\/10.1007\/s10067-017-3835-y. (Epub 20170915 PubMed PMID: 28914375)","journal-title":"Clin Rheumatol"},{"issue":"7","key":"13203_CR14","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1007\/s10067-020-04975-y","volume":"39","author":"TT Ma","year":"2020","unstructured":"Ma TT, Li ZY, Geng YS, Chen M, Zhao MH (2020) Central nervous system involvement in patients with antineutrophil cytoplasmic antibody-associated vasculitis: a study of 29 cases in a single Chinese center. Clin Rheumatol 39(7):2185\u201393. https:\/\/doi.org\/10.1007\/s10067-020-04975-y. (Epub 20200216 PubMed PMID: 32062770)","journal-title":"Clin Rheumatol"},{"issue":"3\u20134","key":"13203_CR15","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1159\/000375492","volume":"73","author":"YH Huang","year":"2015","unstructured":"Huang YH, Ro LS, Lyu RK, Chang HS, Wu YR, Chang KH et al (2015) Wegener\u2019s granulomatosis with nervous system involvement: a hospital-based study. Eur Neurol 73(3\u20134):197\u2013204. https:\/\/doi.org\/10.1159\/000375492. (Epub 20150310 PubMed PMID: 25791920)","journal-title":"Eur Neurol"},{"issue":"9","key":"13203_CR16","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.autrev.2017.07.007","volume":"16","author":"R Andr\u00e9","year":"2017","unstructured":"Andr\u00e9 R, Cottin V, Saraux JL, Blaison G, Bienvenu B, Cathebras P et al (2017) Central nervous system involvement in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): report of 26 patients and review of the literature. Autoimmun Rev 16(9):963\u20139. https:\/\/doi.org\/10.1016\/j.autrev.2017.07.007. (Epub 20170712 PubMed PMID: 28709761)","journal-title":"Autoimmun Rev"},{"issue":"Suppl 3","key":"13203_CR17","doi-asserted-by":"publisher","first-page":"iii79","DOI":"10.1093\/rheumatology\/kez617","volume":"59","author":"A Kronbichler","year":"2020","unstructured":"Kronbichler A, Leierer J, Gauckler P, Shin JI (2020) Comorbidities in ANCA-associated vasculitis. Rheumatology (Oxford) 59(Suppl 3):iii79\u2013iii83. https:\/\/doi.org\/10.1093\/rheumatology\/kez617. (PubMed PMID: 32348518; PubMed Central PMCID: PMCPMC7190116)","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"13203_CR18","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1093\/rheumatology\/kez589","volume":"59","author":"ZS Wallace","year":"2020","unstructured":"Wallace ZS, Fu X, Harkness T, Stone JH, Zhang Y, Choi H (2020) All-cause and cause-specific mortality in ANCA-associated vasculitis: overall and according to ANCA type. Rheumatology (Oxford) 59(9):2308\u201315. https:\/\/doi.org\/10.1093\/rheumatology\/kez589. (PubMed PMID: 31846030; PubMedCentral PMCID: PMCPMC7449813)","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"13203_CR19","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s13023-021-01780-x.PMID:33789679;PMCID:PMC8010942","volume":"16","author":"S Liu","year":"2021","unstructured":"Liu S, Guo L, Fan X, Zhang Z, Zhou J, Tian X, Li M, Zeng X, Wang L, Zhang F (2021) Clinical features of central nervous system involvement in patients with eosinophilic granulomatosis with polyangiitis: a retrospective cohort study in China. Orphanet J Rare Dis 16(1):152. https:\/\/doi.org\/10.1186\/s13023-021-01780-x.PMID:33789679;PMCID:PMC8010942","journal-title":"Orphanet J Rare Dis"},{"issue":"10","key":"13203_CR20","doi-asserted-by":"publisher","first-page":"4616","DOI":"10.1093\/rheumatology\/keab057","volume":"60","author":"M Liapi","year":"2021","unstructured":"Liapi M, Jayne D, Merkel PA, Segelmark M, Mohammad AJ (2021) Venous thromboembolism in ANCA-associated vasculitis: a population-based cohort study. Rheumatology (Oxford) 60(10):4616\u20134623. https:\/\/doi.org\/10.1093\/rheumatology\/keab057. (PMID: 33506869)","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"13203_CR21","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1093\/rheumatology\/keac669","volume":"62","author":"D Tabakovic","year":"2023","unstructured":"Tabakovic D, Smith R, Jayne D, Mohammad AJ (2023) High risk of stroke in ANCA-associated vasculitis-a population-based study. Rheumatology (Oxford) 62(8):2806\u20132812. https:\/\/doi.org\/10.1093\/rheumatology\/keac669. (PMID: 36440920; PMCID: PMC10393431)","journal-title":"Rheumatology (Oxford)"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13203-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-13203-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13203-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T08:08:54Z","timestamp":1756886934000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-13203-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,8]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["13203"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-13203-z","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,8]]},"assertion":[{"value":"2 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Gulen Hatemi has received research grant, lecture fees and fees for serving on an advisory board from Celgene, receiving consulting fees from UCB Pharma, Bayer, Johnson & Johnson, lecture fees from Novartis, Abbvie, Amgen, and UCB Pharma. No other disclosures were reported.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study protocol complied with the Helsinki declaration and was approved by the ethics committee of Istanbul University-Cerrahpasa (E-83045809-604.01.01-362209). Informed consent was not obtained due to the retrospective design of the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"492"}}